| John Gibbons, PHD | |
|
765 Route 70 E, Marlton, NJ 08053-2341 | |
| (800) 370-3651 | |
| Not Available |
| Full Name | John Gibbons |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 765 Route 70 E, Marlton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508106808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 35SI00326800 (New Jersey) | Primary |
| Entity Name | Inetmed Rx2 Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487107363 PECOS PAC ID: 2062796709 Enrollment ID: O20170224002051 |
News Archive
A research group at Uppsala University, Sweden has developed a new responsive coating for implants used in surgery to improve their integration into bone and to prevent rejection. Neutron scattering experiments at the Institut Laue-Langevin (ILL) in Grenoble, France have shown how a protein that promotes bone growth binds to this surface and can be released in a controlled way.
In a Washington Post letter to the editor, Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, and Rafi Ahmed, science committee chairman of the Global HIV Vaccine Enterprise, challenge a recent Washington Post editorial that questioned the scientific progress being made in the search for an HIV vaccine and microbicide. "The search for a safe and effective method to prevent HIV infection and AIDS is a long journey in which we should expect both success and failure," the authors write, before highlighting the lessons learned from the recent microbicide gel study and AIDS vaccine trial in Thailand.
Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.
The longer a child with minor blunt head trauma is observed in the emergency department, the less likely the child is to require computed tomography (CT) scan, according to the results of a study published online Friday in Annals of Emergency Medicine ("Impact of the Duration of Emergency Department Observation on Computed Tomography Use in Children with Minor Blunt Head Trauma").
Selfish bacterial cells that act in their own interests and do not cooperate with their infection-causing colleagues can actually reduce the severity of infection.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Gibbons, PHD 125 Gibbs Ave, Somers Point, NJ 08244-2319 Ph: (609) 816-3252 | John Gibbons, PHD 765 Route 70 E, Marlton, NJ 08053-2341 Ph: (800) 370-3651 |
News Archive
A research group at Uppsala University, Sweden has developed a new responsive coating for implants used in surgery to improve their integration into bone and to prevent rejection. Neutron scattering experiments at the Institut Laue-Langevin (ILL) in Grenoble, France have shown how a protein that promotes bone growth binds to this surface and can be released in a controlled way.
In a Washington Post letter to the editor, Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, and Rafi Ahmed, science committee chairman of the Global HIV Vaccine Enterprise, challenge a recent Washington Post editorial that questioned the scientific progress being made in the search for an HIV vaccine and microbicide. "The search for a safe and effective method to prevent HIV infection and AIDS is a long journey in which we should expect both success and failure," the authors write, before highlighting the lessons learned from the recent microbicide gel study and AIDS vaccine trial in Thailand.
Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.
The longer a child with minor blunt head trauma is observed in the emergency department, the less likely the child is to require computed tomography (CT) scan, according to the results of a study published online Friday in Annals of Emergency Medicine ("Impact of the Duration of Emergency Department Observation on Computed Tomography Use in Children with Minor Blunt Head Trauma").
Selfish bacterial cells that act in their own interests and do not cooperate with their infection-causing colleagues can actually reduce the severity of infection.
› Verified 8 days ago
Dr. Melissa Acquavella-lightfoot, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19 E Main St, Marlton, NJ 08053 Phone: 856-985-9091 Fax: 856-985-9092 | |
Dianna Batalla, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 30 S Maple Ave Ste 203, Marlton, NJ 08053 Phone: 516-225-7043 | |
Christina Treutler, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 765 E Route 70, Building A, Marlton, NJ 08053 Phone: 856-983-3900 | |
Dr. Jacqueline Shall-mccumiskey, PSY. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 525 Route 73 N Ste 104, Marlton, NJ 08053 Phone: 646-479-8068 | |
Dr. Emily Kostelnik, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 525 Route 73 N Ste 104, Marlton, NJ 08053 Phone: 000-000-0000 | |
Dr. Gregory William Joseph, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12000 Lincoln Dr W, Suite 105, Marlton, NJ 08053 Phone: 856-797-0791 Fax: 856-983-3426 | |
Aleksandra Goncharova, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 525 Route 73 N Ste 104, Marlton, NJ 08053 Phone: 201-218-0433 |